UBS O'Connor’s Lombard Medical, Inc. EVAR Stock Holding History

UBS O'Connor’s Portfolio EVAR Stock Details EVAR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-40,000	Closed	-$308K	–	757
2014 Q3	$308K	Hold	40,000	–	–	0.01%	388
2014 Q2	$288K	Buy	+40,000	New	+$326K	﹤0.01%	382

Other funds holding EVAR

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

GLG Partners London, United Kingdom $2.14B AUM 21.14% 1-Year Est. Return

UBS O'Connor's EVAR Position: Q4 2014 in Review

UBS O'Connor sold out of Lombard Medical, Inc. (EVAR) in Q4 2014, closing a stake of 40,000 shares — an estimated $308K sold.

UBS O'Connor first reported a position in EVAR in Q2 2014 and held it in 2 quarters. The position peaked at $308K in Q3 2014. 20 funds tracked by Wall St. Rank hold EVAR as of Q4 2014.

UBS O'Connor reported no remaining Lombard Medical, Inc. position as of Q4 2014 after selling out during the quarter.
UBS O'Connor sold 40,000 Lombard Medical, Inc. shares in Q4 2014, an estimated $308K.
UBS O'Connor first reported a position in Lombard Medical, Inc. in Q2 2014 and held it in 2 quarters.
UBS O'Connor's Lombard Medical, Inc. position peaked at $308K in Q3 2014.
20 funds tracked by Wall St. Rank held Lombard Medical, Inc. as of Q4 2014.

Based on UBS O'Connor's 13F filing for Q4 2014, filed 13 Feb 2015.